Breaking News

PPD, Clinical Ink Partner on Near Real-Time Access to Endpoint Data

Jointly develop systemic lupus erythematosus assessment review process to enhance data quality and research site personnel experiences and efficiencies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PPD, Inc., a global CRO, and Clinical Ink, a global clinical technology company, have jointly developed a systemic lupus erythematosus (SLE) assessment review process designed to simplify operationalizing clinical trials for this chronic autoimmune disease. The companies’ approach focuses on enhancing data quality and research site personnel experiences and efficiencies.   The data collection is a customized PPD version of Clinical Ink’s electronic Lupus Assessment Suite (eLAS). Using eL...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters